Dipna Pharmachem IPO Guidance & Details

Dipna Pharmachem IPO Listing on 8 September 2022
Issued at Rs. 
Listed at Rs.32
Day high Rs. 33.60
Closed at Rs. 33.40

Grey Market News for Dipna Pharmachem IPO#
On 7 September 2022
Grey Market Premium:  Rs. 1 seller

Subscription Trend
On 30 August 2022 @ 5.00 pm
NII (50%) 18,99,300 Shares: 0.78 T
RII (50%) 18,99,300 Shares: 4.75 T
Tot 37,98,600 Shares: 2.77 T

Dipna Pharmachem IPO Details
IPO Date August 25, 2022, to August 30, 2022
IPO Face Value Rs 10 per share
IPO Price Rs 38 per share
IPO Lot Size 3000 Shares
Issue Size 40,02,000 shares of Rs 10
(Aggregating up to Rs 15.21 Cr)
Issue Type Fixed Price Issue IPO
Listing At BSE SME
Retail Shares Offered 50% of the net offer
NII (HNI) Shares Offered 50% of the net offer

Retail Quota: 50 % / 1899300 Shares
Minimum 3000 Rs 114,000
Maximum 3000 Rs 114,000
Retail: 633 Applications required for one -ime subscriptions.

Dipna Pharmachem IPO Timetable 
IPO Opening Date August 25, 2022
IPO Closing Date August 30, 2022
Basis of Allotment Sept 2, 2022
Initiation of Refunds Sept 2, 2022
Credit of Shares to Demat Sept 5, 2022
IPO Listing Date Sept 6, 2022

Dipna Pharmachem IPO Business 

The Company is engaged in the trading and distribution of wide range of pharmaceutical raw material which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. Presently the product portfolio comprises of 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovascular, Anti – Bacteria, Quinolones, Veterinary, Anti – Virus, Anti – Inflammatory, Neuropsychiatry, Steroid Hormone, other etc. Being a trading and distribution company, it has pan India market for the products. The Company had also started the selling of chemicals on commission basis in the financial year 2022 the Company had earned commission income of Rs 127.50 lacs. The Company is doing trading in Ahmedabad and surrounding area of Ahmedabad.

Its Products
AIPs is known as bulk drugs or bulk actives are the principal ingredients used in making finished dosages in the form of capsules, tablets, liquid or other forms of dosage, with the addition of other APIs or inactive ingredients. It believes that timely and committed delivery is an ongoing process of building and sustaining relationships. Its strength lies in understanding the requirements of the customer and its execution capabilities. This has enabled it to get repeated orders from its existing customers and attract new customers. An active ingredient is the ingredient in a pharmaceutical drug or pesticide that is biologically active. The similar terms active pharmaceutical ingredient and bulk active are also used in medicine, and the term active substance may be used for natural products.
For more information about the company, Click www.dipnapharmachem.com

Promoters of Dipna Pharmachem IPO

Mr. Keyur Dipakkumar Shah

Dipna Pharmachem: Objects of the IPO
To Meet the working Capital Requirements
Registered office of Dipna Pharmachem 
A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba,
Ahmedabad – 380 055, Gujarat,
Company Secretary and Compliance Officer: Ms. Khushboo Jethaliya,

Lead Manager of Dipna Pharmachem IPO
INTERACTIVE FINANCIAL SERVICES Limited

SME IPO Financial & Analytical Ratios#
Earnings per Share 2019-20 Rs 16.86
Earnings per Share 2020-21 Rs 6.91
Earnings per Share 2021-22 Rs 333.40
Return on Net Worth: 19-20: 10.78 %
Return on Net Worth: 20-21: 4.23 %
Return on Net Worth: 21-22: 67.12 %
Book Value of the Share as on 31.3.22 Rs 496.74
NAV after the IPO Rs. 19.59
Offer Price Rs. 38

IPO Peer Comparison:
Earum Pharmaceuticals @ PE Multiple of 31.33
A-1 Acid Limited @ PE Multiple of 107.51

Observation by Paresh Gordhandas (Research Analyst)

Guidance: Will be updated soon

# This is only coverage of News related to Grey Market. We do not deal in grey market premium or Subject to rates, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.